MTD-211

N/A

Report date: 2023/03/12 16:34:23

Base Information

Drug NameMTD-211
Drug Alias NameBrexpiprazole long-acting injectable - MidatechMTD-211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor agonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiodexa Pharmaceuticals PLC
China Registration ClassN/A

Develop Information

Active CompaniesBiodexa Pharmaceuticals PLC
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A